Inventor · disambiguated record
Jianliang Shi
Also filed as: SHI JIANLIANG
19 granted patents·16 pending applications·105 citations·filing 2005–2024
92Inventor score
Files withBRISTOL MYERS SQUIBB CO28BOY KENNETH M3FUJIAN RUIHONG TEXTILE TECH CO LTD2THOMPSON III LORIN A1VERZEGNASSI RODOLFO1
Top patents by PatentIndex Score
35 records- 0195US11767322B2Triazolopyridinyl compounds as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2021·Granted Sep 26, 2023·3 cites·66 claims
- 0294US8486952B2Compounds for the reduction of β-amyloid productionBOY KENNETH M·Filed 2010·Granted Jul 16, 2013·34 cites·15 claims
- 0393US10913738B2Aminotriazolopyridines as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Feb 9, 2021·7 cites·14 claims
- 0493US8637525B2Compounds for the reduction of beta-amyloid productionBOY KENNETH M·Filed 2011·Granted Jan 28, 2014·39 cites·5 claims
- 0589US9221796B2Selective NR2B antagonistsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Dec 29, 2015·5 cites·12 claims
- 0687US7388007B2Gamma-lactams as beta-secretase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Jun 17, 2008·6 cites·8 claims
- 0786US7902218B2Substituted tetrahydroisoquinolines as β-secretase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Mar 8, 2011·5 cites·7 claims
- 0881US11440913B2Aminoimidazopyridazines as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Sep 13, 2022·2 cites·14 claims
- 0979US12110290B2Triazolopyridinyl compounds as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2023·Granted Oct 8, 2024·0 cites·14 claims
- 1079US2025074909A1Aminotriazolopyridines as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2024·Application pending·0 cites
- 1178US2024425505A1Triazolopyridinyl compounds as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2024·Application pending·0 cites
- 1276US8349880B2Bicyclic compounds for the reduction of beta-amyloid productionBRISTOL MYERS SQUIBB CO·Filed 2010·Granted Jan 8, 2013·4 cites·6 claims
- 1373US2021121453A1Selective nr2b antagonistsBRISTOL MYERS SQUIBB CO·Filed 2020·Application pending·0 cites
- 1469US2020163949A1Selective nr2b antagonistsBRISTOL MYERS SQUIBB CO·Filed 2020·Application pending·0 cites
- 1569US2019314358A1Selective nr2b antagonistsBRISTOL MYERS SQUIBB CO·Filed 2019·Application pending·0 cites
- 1668US2019117638A1Selective nr2b antagonistsBRISTOL MYERS SQUIBB CO·Filed 2018·Application pending·0 cites
- 1767US12157733B2Aminotriazolopyridines as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Dec 3, 2024·0 cites·6 claims
- 1866US2018250283A1Selective nr2b antagonistsBRISTOL MYERS SQUIBB CO·Filed 2018·Application pending·0 cites
- 1965US2018000807A1Selective nr2b antagonistsBRISTOL MYERS SQUIBB CO·Filed 2017·Application pending·0 cites
- 2065US2018110766A1Selective nr2b antagonistsBRISTOL MYERS SQUIBB CO·Filed 2017·Application pending·0 cites
- 2164US2017258777A1Selective NR2B AntagonistsBRISTOL MYERS SQUIBB CO·Filed 2017·Application pending·0 cites
- 2259US2016081995A1Selective NR2B AntagonistsBRISTOL MYERS SQUIBB CO·Filed 2015·Application pending·0 cites
- 2358US2013178462A1Compounds for the reduction of beta-amyloid productionBRISTOL MYERS SQUIBB CO·Filed 2013·Application pending·0 cites
- 2456US7981913B2Isophthalates as beta-secretase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2010·Granted Jul 19, 2011·0 cites·1 claims
- 2556US7745470B2Isophthalates as beta-secretase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Jun 29, 2010·0 cites·2 claims
- 2652US2011059940A12-Aryl Glycinamide DerivativesBRISTOL MYERS SQUIBB CO·Filed 2009·Application pending·0 cites
- 2751US12329241B2Waterproof and moisture-permeable shoe upper and preparation method thereforFUJIAN RUIHONG TEXTILE TECH CO LTD·Filed 2022·Granted Jun 17, 2025·0 cites·9 claims
- 2851US2015336975A1Compounds for the reduction of beta-amyloid productionBRISTOL MYERS SQUIBB CO·Filed 2015·Application pending·0 cites
- 2950US2015152089A1Compounds for the reduction of beta-amyloid productionBRISTOL MYERS SQUIBB CO·Filed 2015·Application pending·0 cites
- 3049US2023225458A1Three-dimensional flexing resistance waterproof and moisture-permeable shoe upper and preparation method thereforFUJIAN RUIHONG TEXTILE TECH CO LTD·Filed 2022·Application pending·0 cites
- 3146US7601751B2Indole acetic acid acyl guanidines as β-secretase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Oct 13, 2009·0 cites·6 claims
- 3244US11618753B2Aminopyrrolotriazines as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Apr 4, 2023·0 cites·9 claims
- 3339US8710061B2Compounds for the reduction of β-amyloid productionBOY KENNETH M·Filed 2012·Granted Apr 29, 2014·0 cites·18 claims
- 3435US8604024B2Compounds for the reduction of beta-amyloid productionTHOMPSON III LORIN A·Filed 2012·Granted Dec 10, 2013·0 cites·8 claims
- 3529US8315580B2Process for detecting transmitted symbols based on a ternary alphabet and corresponding receiverVERZEGNASSI RODOLFO·Filed 2010·Granted Nov 20, 2012·0 cites·15 claims
Join the waitlist — get patent alerts
Get an alert when Jianliang Shi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →